1. Home
  2. BVN vs EWTX Comparison

BVN vs EWTX Comparison

Compare BVN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVN
  • EWTX
  • Stock Information
  • Founded
  • BVN 1953
  • EWTX 2017
  • Country
  • BVN Peru
  • EWTX United States
  • Employees
  • BVN N/A
  • EWTX N/A
  • Industry
  • BVN Metal Mining
  • EWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BVN Basic Materials
  • EWTX Health Care
  • Exchange
  • BVN Nasdaq
  • EWTX Nasdaq
  • Market Cap
  • BVN 3.5B
  • EWTX 3.3B
  • IPO Year
  • BVN 1996
  • EWTX 2021
  • Fundamental
  • Price
  • BVN $12.04
  • EWTX $32.20
  • Analyst Decision
  • BVN Buy
  • EWTX Buy
  • Analyst Count
  • BVN 2
  • EWTX 6
  • Target Price
  • BVN $16.50
  • EWTX $41.17
  • AVG Volume (30 Days)
  • BVN 1.1M
  • EWTX 688.5K
  • Earning Date
  • BVN 10-30-2024
  • EWTX 11-07-2024
  • Dividend Yield
  • BVN 0.61%
  • EWTX N/A
  • EPS Growth
  • BVN 329.23
  • EWTX N/A
  • EPS
  • BVN 1.41
  • EWTX N/A
  • Revenue
  • BVN $1,108,813,000.00
  • EWTX N/A
  • Revenue This Year
  • BVN N/A
  • EWTX N/A
  • Revenue Next Year
  • BVN N/A
  • EWTX N/A
  • P/E Ratio
  • BVN $8.32
  • EWTX N/A
  • Revenue Growth
  • BVN 35.82
  • EWTX N/A
  • 52 Week Low
  • BVN $8.86
  • EWTX $5.93
  • 52 Week High
  • BVN $18.84
  • EWTX $38.12
  • Technical
  • Relative Strength Index (RSI)
  • BVN 38.54
  • EWTX 48.00
  • Support Level
  • BVN $12.09
  • EWTX $29.82
  • Resistance Level
  • BVN $12.48
  • EWTX $32.80
  • Average True Range (ATR)
  • BVN 0.40
  • EWTX 1.85
  • MACD
  • BVN 0.00
  • EWTX -0.62
  • Stochastic Oscillator
  • BVN 27.56
  • EWTX 28.67

About BVN Buenaventura Mining Company Inc.

Compañía de Minas Buenaventura SAA is a Peruvian precious metals producing company with experience in mine exploration, development, construction and operation activities.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Share on Social Networks: